Cargando…

hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Shoujun, Xiong, Xiaoyan, Tang, Bo, Ji, Tingting, Li, Xiaoying, Qu, Xiaolei, Li, Weiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257373/
https://www.ncbi.nlm.nih.gov/pubmed/34257820
http://dx.doi.org/10.1155/2021/8814163
_version_ 1783718299501068288
author Bai, Shoujun
Xiong, Xiaoyan
Tang, Bo
Ji, Tingting
Li, Xiaoying
Qu, Xiaolei
Li, Weiliang
author_facet Bai, Shoujun
Xiong, Xiaoyan
Tang, Bo
Ji, Tingting
Li, Xiaoying
Qu, Xiaolei
Li, Weiliang
author_sort Bai, Shoujun
collection PubMed
description Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal tubules from diabetic-induced injury by repressing KDM6A, a histone lysine demethylase regulating E-cadherin expression. Lower E-cadherin expression is related to a higher level of KDM6A, while E-cadherin is promoted upon treatment with the KDM6A inhibitor GSK-J4 in both high glucose- (HG-) induced HK2 cells and the kidneys from streptozotocin- (STZ-) induced type 1 diabetic mice. However, overexpression or RNA silencing of E-cadherin fails to alter KDM6A expression. We also show that the upregulation of KDM6A is associated with the increased methylation level of the E-cadherin promoter. Then, the target prediction results and a dual-luciferase assay show that hsa-miR-199b-3p is a new miRNA that targets KDM6A. Overexpression of hsa-miR-199b-3p increases E-cadherin expression and prevents EMT through repressing KDM6A expression in HG-induced HK2 cells. In contrast, inhibitor-induced hsa-miR-199b-3p knockdown has opposite effects, as it decreases E-cadherin level and worsens EMT, accompanied by increased levels of KDM6A. Besides, Mir199b-knockout mice without mmu-miR-119b-3p expression exhibit more renal tubule dysfunction and more serious kidney tissue damage upon treatment with STZ. These results demonstrate that hsa-miR-199b-3p improves E-cadherin expression and prevents the progression of DN through targeting KDM6A. miR-199b-3p could be a future biomarker or target for the diagnosis or treatment of DN.
format Online
Article
Text
id pubmed-8257373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82573732021-07-12 hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy Bai, Shoujun Xiong, Xiaoyan Tang, Bo Ji, Tingting Li, Xiaoying Qu, Xiaolei Li, Weiliang Oxid Med Cell Longev Research Article Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The association between epithelial-mesenchymal transition (EMT) and fibrosis is quite ascertained, but its link to eventual tubule dysfunction is missing. Here, we show that human microRNA- (hsa-miR-) 199b-3p protects renal tubules from diabetic-induced injury by repressing KDM6A, a histone lysine demethylase regulating E-cadherin expression. Lower E-cadherin expression is related to a higher level of KDM6A, while E-cadherin is promoted upon treatment with the KDM6A inhibitor GSK-J4 in both high glucose- (HG-) induced HK2 cells and the kidneys from streptozotocin- (STZ-) induced type 1 diabetic mice. However, overexpression or RNA silencing of E-cadherin fails to alter KDM6A expression. We also show that the upregulation of KDM6A is associated with the increased methylation level of the E-cadherin promoter. Then, the target prediction results and a dual-luciferase assay show that hsa-miR-199b-3p is a new miRNA that targets KDM6A. Overexpression of hsa-miR-199b-3p increases E-cadherin expression and prevents EMT through repressing KDM6A expression in HG-induced HK2 cells. In contrast, inhibitor-induced hsa-miR-199b-3p knockdown has opposite effects, as it decreases E-cadherin level and worsens EMT, accompanied by increased levels of KDM6A. Besides, Mir199b-knockout mice without mmu-miR-119b-3p expression exhibit more renal tubule dysfunction and more serious kidney tissue damage upon treatment with STZ. These results demonstrate that hsa-miR-199b-3p improves E-cadherin expression and prevents the progression of DN through targeting KDM6A. miR-199b-3p could be a future biomarker or target for the diagnosis or treatment of DN. Hindawi 2021-06-27 /pmc/articles/PMC8257373/ /pubmed/34257820 http://dx.doi.org/10.1155/2021/8814163 Text en Copyright © 2021 Shoujun Bai et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bai, Shoujun
Xiong, Xiaoyan
Tang, Bo
Ji, Tingting
Li, Xiaoying
Qu, Xiaolei
Li, Weiliang
hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title_full hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title_fullStr hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title_full_unstemmed hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title_short hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
title_sort hsa-mir-199b-3p prevents the epithelial-mesenchymal transition and dysfunction of the renal tubule by regulating e-cadherin through targeting kdm6a in diabetic nephropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257373/
https://www.ncbi.nlm.nih.gov/pubmed/34257820
http://dx.doi.org/10.1155/2021/8814163
work_keys_str_mv AT baishoujun hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT xiongxiaoyan hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT tangbo hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT jitingting hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT lixiaoying hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT quxiaolei hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy
AT liweiliang hsamir199b3ppreventstheepithelialmesenchymaltransitionanddysfunctionoftherenaltubulebyregulatingecadherinthroughtargetingkdm6aindiabeticnephropathy